Bragar Eagel & Squire is Investigating Certain Officers and Directors of comScore, Zuora, AMC Entertainment, and Arrowhead Pharmaceuticals and Encourages Investors to Contact the Firm
March 10, 2020 16:16 ET
|
Bragar Eagel & Squire
NEW YORK, March 10, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of comScore, Inc. (NASDAQ:...
ARWR LOSS NOTICE: Rosen Law Firm Reminds Arrowhead Pharmaceuticals, Inc. Investors of Important Deadline in Class Action - ARWR
January 06, 2017 16:45 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 06, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Arrowhead Pharmaceuticals, Inc. securities (NASDAQ:ARWR) from May 11, 2015...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Arrowhead Pharmaceuticals, Inc. - ARWR
December 23, 2016 16:42 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 23, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Arrowhead Pharmaceuticals,...
New Arrowhead Analyst Issues Updated Diligence and Valuation Report on Hemispherx Biopharma
September 30, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announces that Arrowhead BID issued an analyst report on September 29, 2015,...
Midtown Partners & Co, LLC Initiates Coverage and Arrowhead b.i.d. Issues Coverage Update on Hemispherx Biopharma
April 28, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, April 28, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") reported today that Midtown Partners &Co, LLC initiates coverage of...
Arrowhead Issues Diligence and Valuation Report on Hemispherx Biopharma
January 09, 2015 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 9, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announces that Arrowhead BID issued an analyst report on Thursday, January...